• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATX 0.00% 6.1¢

AMPLIA THERAPEUTICS LIMITED

Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development... Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development company. The Company is focused on developing proprietary, orally available, small molecule Focal Adhesion Kinase (FAK) inhibitors as candidate drugs for the treatment of cancer and various fibrotic diseases. The Company's pipeline includes narmafotinib (AMP945) and AMP886. narmafotinib is a selective and potent inhibitor of FAK and is in clinical development for pancreatic cancer and advanced preclinical development for idiopathic pulmonary fibrosis (IPF). The Company's second pipeline drug, AMP886, inhibits FAK and inhibits two key disease drug targets (VEGFR3 and FLT3). This drug is being evaluated in preclinical models of cancer. Its fibrosis program uses its FAK inhibitors to block fibrosis and cell migration in cancers. Its cancer Program is directed at using its FAK inhibitors to block FAK activity in the cancer cells and the surrounding tissue and therefore block survival/proliferation signals.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ATX 16:43 0 94
16:43 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  94 
ATX 16:04 0 92
16:04 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  92 
ATX 19/07/24 0 159
Metals & Mining SECTOR NEWS

Infini Resources continues winning streak having identified major fault system and magnetic anomalies

I88
22 Jul 2024
INFINI RESOURCES LIMITED
19/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  159 
ATX 19/07/24 0 161
19/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  161 
ATX 17/07/24 0 208
17/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  208 
ATX 17/07/24 0 184
17/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  184 
ATX 17/07/24 21 4.2K
17/07/24 Last post  brunski Comments Created with Sketch.  21  Views Created with Sketch.  4.2K 
ATX 11/07/24 16 3.7K
11/07/24 Last post  Duke2 Comments Created with Sketch.  16  Views Created with Sketch.  3.7K 

See All Discussions arrow Created with Sketch.

Timeline

Proposed issue of securities - ATX
22 Jul 16:23
 
Notice of Annual General Meeting/Proxy Form
22 Jul 15:44
 
Section 708A Cleansing Notice
19 Jul 17:18
 
Application for quotation of securities - ATX
19 Jul 16:47
 
Proposed issue of securities - ATX
17 Jul 17:12
 
Application for quotation of securities - ATX
17 Jul 16:38
 
View More arrow Created with Sketch.
(20min delay)
Last
6.1¢
Change
0.000(0.00%)
Mkt cap ! $16.67M
Open High Low Value Volume
6.4¢ 6.4¢ 6.1¢ $9.419K 149.7K

Buyers (Bids)

No. Vol. Price($)
3 39253 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.1¢ 12705 1
View Market Depth
Last trade - 15.59pm 22/07/2024 (20 minute delay) ?
Last
6.1¢
  Change
0.000 ( 3.17 %)
Open High Low Volume
6.1¢ 6.1¢ 6.1¢ 32667
Last updated 15.57pm 22/07/2024 ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.